Curioni-Fontecedro et al. [58], through an immunogenicity study of MAGE-C1/CT7 antigen in vivo, showed that this CTA was responsible for the high frequency of specific IgG antibodies in MM patients. This evidence concerns the gene MAGEC1 and Miyoshi myopathy.